Patients were randomized to receive either tamoxifen @ mg/day plus tegafur-uracil @ mg/day ( TU ) for @ years or six courses of a @-day cycle of doxorubicin @ mg/m ( @ ) plus cyclophosphamide @ mg/m ( @ ) on day @ along with tamoxifen ( ACT ) given for @ years as adjuvant therapy .